GILEAD SCIENCES, INC. (GILD)
Clinical trial NCT07047716 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 350 → 339 participants 3. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT07047716 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 350 → 339 participants 3. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT06741228: primary completion date: 2026-05-01 → 2026-07-01.
Clinical trial NCT07193199: primary completion date: 2026-05-24 → 2026-06-01.
Clinical trial NCT07540143 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-15 → 2026-06-16
Clinical trial NCT07079397 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. primary completion date: 2027-12-01 → 2026-12-01
Clinical trial NCT06159335 updates: 1. completion date: 2026-06-01 → 2027-06-01 2. primary completion date: 2026-06-01 → 2027-06-01
Clinical trial NCT04188548 updates: 1. enrollment: 500 → 379 participants 2. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT06085924: enrollment: 8252912 → 2315187 participants.
Clinical trial NCT07565545: enrollment: 110 → 120 participants.
Clinical trial NCT03247023 updates: 1. primary completion date: 2021-12-08 → 2023-09-06 2. enrollment: 61 → 65 participants